![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Cynosure Wins FDA 510(k) Clearance for SculpSure
Cynosure Wins FDA 510(k) Clearance for SculpSure
![](https://www.fdanews.com/ext/resources/test/Device_Images4/lipids.jpg?t=1433878514&width=430)
Cynosure’s SculpSure — the first hyperthermic laser treatment for noninvasive lipolysis of the flanks — has gained FDA 510(k) clearance, the Westford, Mass., devicemaker announced Tuesday. The company plans a product launch later this year.
Consisting of an applicator system capable of targeting many parts of the body, the hands-free device disrupts subcutaneous fat cells without the need for surgery. Treatment takes about 25 minutes for an individual area, the devicemaker says.
During a multicenter clinical trial, patients demonstrated a significant reduction in fat layer thickness during six- and 12-week follow-ups, the company claims.
Last year, the WHO estimated 1.3 billion adults were overweight. — Jason Scott
Upcoming Events
-
21Oct